» Articles » PMID: 38248077

Differentiation Between Parkinson's Disease and the Parkinsonian Subtype of Multiple System Atrophy Using the Magnetic Resonance T1w/T2w Ratio in the Middle Cerebellar Peduncle

Overview
Specialty Radiology
Date 2024 Jan 22
PMID 38248077
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple system atrophy with predominant parkinsonism (MSA-P) can hardly be distinguished from Parkinson's disease (PD) clinically in the early stages. This study investigated whether a standardized T1-weighted/T2-weighted ratio (sT1w/T2w ratio) can effectively detect degenerative changes in the middle cerebellar peduncle (MCP) associated with MSA-P and PD and evaluated its potential to distinguish between these two diseases. We included 35 patients with MSA-P, 32 patients with PD, and 17 controls. T1w and T2w scans were acquired using a 1.5-T MR system. The MCP sT1w/T2w ratio was analyzed via SPM12 using a region-of-interest approach in a normalized space. The diagnostic performance of the MCP sT1w/T2w ratio was compared between the MSA-P, PD, and controls. Patients with MSA-P had significantly lower MCP sT1w/T2w ratios than patients with PD and controls. Furthermore, MCP sT1w/T2w ratios were lower in patients with PD than in the controls. The MCP sT1w/T2w ratio showed excellent or good accuracy for differentiating MSA-P or PD from the control (area under the curve (AUC) = 0.919 and 0.814, respectively) and substantial power for differentiating MSA-P from PD (AUC = 0.724). Therefore, the MCP sT1w/T2w ratio is sensitive in detecting degenerative changes in the MCP associated with MSA-P and PD and is useful in distinguishing MSA-P from PD.

References
1.
Du G, Lewis M, Sica C, Kong L, Huang X . Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson disease. Ann Neurol. 2018; 85(1):96-104. PMC: 6342624. DOI: 10.1002/ana.25376. View

2.
Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E . Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain. 2002; 125(Pt 5):1070-83. DOI: 10.1093/brain/awf117. View

3.
Wu T, Hallett M . The cerebellum in Parkinson's disease. Brain. 2013; 136(Pt 3):696-709. PMC: 7273201. DOI: 10.1093/brain/aws360. View

4.
Brettschneider J, Irwin D, Boluda S, Byrne M, Fang L, Lee E . Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type. Neuropathol Appl Neurobiol. 2016; 43(4):315-329. PMC: 5362365. DOI: 10.1111/nan.12362. View

5.
Wenning G, Geser F, Krismer F, Seppi K, Duerr S, Boesch S . The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol. 2013; 12(3):264-74. PMC: 3581815. DOI: 10.1016/S1474-4422(12)70327-7. View